Marketing an Aesthetic Clinic in Singapore: The Complete MOH-Compliant Playbook

Aesthetic clinic advertising in Singapore sits under the Healthcare Services Act and the Healthcare Services (Advertisement) Regulations administered by MOH, plus the SMC ethical guidelines. Between them they restrict before/after imagery, testimonials about outcomes, price promotions and superlative claims — the staples of unregulated beauty marketing.

Requirements are described here in practical terms — always confirm specifics with MOH or your own adviser, and use our free MOH Ad Compliance Checker to self-check draft copy before it goes anywhere near a media buyer.

The scannable version of what governs aesthetic clinic advertising in Singapore, with the detail behind each point in the sections that follow:

• No before-and-after imagery. Visual outcome comparisons are restricted regardless of consent — this is stricter than Malaysia's consent-based approach to the same imagery.
• No outcome testimonials. Patient accounts of results are not permitted in advertising; service-experience testimonials (how the visit felt, how staff treated them) sit in a narrower, more cautiously handled category.
• No price promotions on treatments. Discount-driven, time-limited pricing on medical aesthetic procedures is treated as inducement.
• No guarantees or superlatives. "Best," "guaranteed," "permanent" and similar claims are not defensible advertising language.
• No self-diagnosis prompts. Advertising cannot lead a reader to self-diagnose a condition and self-select a treatment without a consultation.
• Consultation-first framing required. The compliant structure positions every treatment decision as something assessed in consultation, not decided from an ad.
• DNC Registry compliance for follow-up. Once a lead is followed up by call or SMS, Singapore's Do Not Call rules apply on top of PDPA.
• No naming prescription-only medicines or professional-use devices to the public. This is the rule most clinics are surprised by, and HSA/MOH's own guidance names botulinum toxin and hyaluronic acid dermal fillers as examples. Detailed below.
• No gifts, vouchers or lucky draws tied to a service. Regulation 15. Referral rewards may exist, but may not be advertised.
• No advertising the prospect of a medical certificate. "MC in minutes" framing treats a clinical assessment as a service feature.

The pattern across all four restrictions is the same: Singapore's rules push advertising away from "here is the result, want it too" and toward "here is the process, come find out if it suits you."

That is a harder brief to write well than a before/after post, but it converts a more qualified patient — someone who books because they trust the practice, not because they saw a result and want it copied onto themselves regardless of suitability.

This one sits outside the Advertisement Regulations and catches clinics that are otherwise careful. Under the Health Products Act framework, Prescription-Only Medicines (POM) and Professional-Use-Only medical devices may not be advertised to the public at all — and HSA/MOH's own guidance for PHMCA/HCSA licensees names botulinum toxin (Botox) and hyaluronic acid dermal fillers as examples in exactly that category.

The reasoning given is not commercial: these products' use depends on a doctor's clinical judgement and an informed discussion with the patient, not on a marketing-driven request for a named product.

Advertising the consultation, not the product

What that means in practice is uncomfortable for most aesthetic clinic ad accounts, because the named product is the search demand. The compliant structure is to advertise the consultation and the clinical concern rather than the product: a page about facial volume loss or dynamic lines, assessed in consultation, is a different asset from a page selling a named injectable.

Organic search complicates it further — a patient searching a brand name will find brand-name content, and the compliant answer is educational, non-promotional information rather than promotional copy carrying the same words.

Sourcing note

Sourcing note, because it matters here more than usual: this rule is one of the two on this page verified directly against the primary document — HSA/MOH's "Guidance for PHMCA/HCSA Licensees on Advertisement Controls of Health Products", §4.2 and Appendix A, fetched and read in full.

The Advertisement Regulations items above are cited by regulation number via a specialist Singapore healthcare-marketing compliance guide, because Singapore Statutes Online blocks automated retrieval; the regulation numbers are stated so you can check each against the statute yourself. This is general information, not legal advice.

Regulation 15 prohibits advertising any gift, freebie, lucky draw or voucher tied to purchasing a healthcare service — the test is whether the benefit is designed to solicit consumption of the service. Referral reward programmes are the subtle case: they are not banned, but they may not be advertised.

A patient may only learn about one at the point of payment. That single distinction invalidates a large share of the standard clinic growth playbook — "refer a friend, both get $50 off" is a normal e-commerce mechanic and a compliance problem here.

Payment plans work the same way: allowed, but disclosed at the point of payment rather than used as a promotional hook.

Pricing and medical certificate promotion

And on pricing itself, the safe reading of regulation 5(1)(g), which bars presenting information in a way that solicits or encourages use of the service, is exact, final prices — no "from", no "as low as", no crossed-out usual price, no percentage discount, no validity-period urgency.

The related trap is medical certificate promotion: advertising the prospect of obtaining an MC through a service — "MC in minutes", or framing sick leave as a fast, guaranteed outcome of a teleconsultation — runs against regulation 5, which requires advertising to be accurate and not misleading, and bars creating an unjustified expectation or soliciting use of the service.

An MC records a doctor's clinical assessment; it is not a product feature.

Clinics operating on both sides of the causeway need to hold two rulebooks in mind, and the differences are specific enough to catch out a campaign built for one market and copied to the other.

Both Malaysia's KKM/MDC framework (see the full KKM and MDC guide) and Singapore's MOH framework restrict guaranteed outcomes, superlative claims and comparative advertising against named competitors — that overlap is large and gives a starting template that mostly transfers.

Where they diverge matters more:

• Malaysia's before-and-after restrictions are consent- and context-dependent, with some controlled use permitted; Singapore's are closer to an outright restriction regardless of consent.
• Malaysia has no national Do Not Call registry governing marketing follow-up; Singapore's DNC Registry makes follow-up timing and consent wording a compliance question, not just a courtesy.
• And testimonials sit in a narrower band in Singapore than the "medical endorsement" test Malaysia applies — Singapore is generally the more conservative jurisdiction of the two on nearly every axis, which is the safe assumption to default to when a rule's application to a specific piece of creative is ambiguous.

The practical consequence for a dual-market clinic: build creative to Singapore's stricter standard by default, and it will almost always clear Malaysia's rules too — building to Malaysia's standard first and trying to loosen it for Singapore is the direction that gets campaigns rejected or flagged.

Singapore CPLs run higher than Malaysia and must be budgeted in SGD. For aesthetic clinics, expect Meta cost per lead around SGD 25–80 and cost per booked consultation around SGD 120–350, depending on treatment mix and qualification.

Because acquisition costs more, the qualification flow and show-rate matter even more than in Malaysia — a no-show in SGD is an expensive no-show. For the cross-market comparison against Malaysian benchmarks, see the Singapore vs Malaysia ad costs breakdown, and for the full ranges across every channel, our MY & SG benchmarks resource.

The compliance restrictions above interact directly with these economics. A clinic that can't lead with before/after imagery or price promotions has to work harder in the first few seconds of a scroll to earn attention —

• which typically means the creative production bar for a compliant, high-converting Singapore aesthetic ad is higher than for an unregulated category,
• and budget for creative testing should be planned accordingly rather than treated as an afterthought.

Singapore adds a compliance layer Malaysia doesn't: the Do Not Call (DNC) Registry on top of PDPA (SG). The moment you follow up a lead by call or SMS, DNC rules apply — so consent wording on the form and a DNC-aware follow-up process are part of the campaign, not optional.

We cover this in depth in our DNC & PDPA (SG) post.

This layer catches Malaysian clinics expanding into Singapore off guard most often, because Malaysia has no equivalent registry governing marketing follow-up calls — a lead-gen funnel that's perfectly compliant in KL can create real regulatory exposure the moment the same follow-up sequence runs against a Singapore phone number.

DNC compliance in practice

In practice, DNC compliance means checking a lead's number against the registry before any call or SMS follow-up, obtaining explicit consent for marketing contact at the point of enquiry (not assuming consent because someone filled a form), and keeping a record of that consent in case it's ever queried.

WhatsApp sits in a different category from calls and SMS under current guidance, which is one reason WhatsApp-first follow-up has become the default structure for Singapore lead funnels — it sidesteps the DNC question entirely for the initial contact while still allowing a fast, personal response.

The clinics that perform best under Singapore's restrictions build their funnel around three assets the rules don't touch: practitioner credibility (qualifications, experience, specific expertise), process transparency (what a consultation actually involves, what questions get asked, how a treatment plan gets built), and facility quality (a clean, professional, trustworthy environment).

None of these require a testimonial or a before/after photo to communicate, and all three are exactly what a patient comparing clinics for a decision this personal is actually looking for.

The mistake we see most often in campaigns ported over from Malaysia is treating these three assets as filler content around a testimonial-led structure, rather than building the entire creative strategy around them from the start.

How treatment category changes the picture

Treatment category also changes how tightly these restrictions bite. Injectables (Botox, fillers) sit at the most restricted end, because outcome variability and the medical risk profile draw the closest regulatory attention — education-led content explaining what the treatment involves and who is and isn't a suitable candidate is the safest and, in our experience, best-converting structure.

Energy-based devices (laser, HIFU, RF) have slightly more room because the "before/after" instinct is weaker for these categories to begin with — process and technology explainer content performs well without needing to lean on restricted formats.

Body contouring and injectables marketed as quick, dramatic transformations are where clinics most often drift toward non-compliant language, because the category's own marketing conventions elsewhere in the region lean heavily on exactly the imagery Singapore restricts.

The clinics that stay compliant without slowing their marketing down treat compliance as a step built into creative production, not a final check that happens after copy is written.

That means briefing every creative concept against the restricted list before a single asset is produced, rather than writing freely and then editing out violations — the second approach produces watered-down versions of non-compliant ideas, which often still carry the spirit of the restriction even after the letter is fixed.

A practical structure

A practical structure: maintain a short internal checklist mirroring the restricted list above, have every ad concept reviewed against it before production begins, and keep a record of what was approved and why, since MOH and platform reviewers can both query creative after the fact.

This is slower for the first few campaigns and then becomes close to instant once the creative team internalises where the lines sit.

Platform review as a second layer

Platform review adds a second layer worth planning for separately from MOH compliance.

Meta's own health and beauty advertising policies are stricter than general advertising policy and don't always map cleanly onto Singapore's specific restrictions — creative that would satisfy MOH can still be rejected by Meta's automated review for using medical terminology or implying a health claim, and the reverse is also true.

Budgeting review time for both layers, rather than assuming MOH-compliant automatically means platform-approved, avoids the common experience of a fully compliant ad sitting in "in review" limbo for days before either passing or requiring a resubmission.

Ethical aesthetic advertising in Singapore isn't a separate standard from MOH-compliant advertising — it's the same discipline, described from the patient's side rather than the regulator's.

The restricted list above (no guaranteed outcomes, no before/after imagery without proper consent and context, no comparative or superlative claims, no impulse-purchase pricing pressure) exists because aesthetic decisions are medical decisions, and a patient choosing a practitioner deserves honest information about outcomes, risks and realistic expectations — not a sales pitch dressed as one.

Practices that treat these rules as a floor rather than an obstacle tend to convert better anyway, because credibility and process transparency read as trustworthy to exactly the patients evaluating a procedure on their own face or body.

Five recurring creative questions, each answered by the regulation that decides it (Healthcare Services (Advertisement) Regulations 2021, current version on Singapore Statutes Online, checked 9 October 2026):

Sign-off and responsibility

The clinic, as licensee, must make sure every advertisement it or its agency publishes complies, and must have a non-compliant one corrected or withdrawn once it knows of it. An agency acting for the clinic is an "authorised person" under the Regulations (regulations 2, 5 and 17).

Testimonials and reviews

Reviews, testimonials and endorsements cannot be used to advertise the clinic's service. The exception is a review a patient gave directly to the clinic, shown on the clinic's own premises, website or social account and not reproduced (regulation 14).

Before-and-after images

No photograph, picture or video showing a person before and after, or only after, a treatment, in one advertisement or spread across several. Showing them to a patient during a consultation remains allowed (regulation 5).

Influencer content

A creator's endorsement of the clinic's service is an endorsement under regulation 14, and a joint promotion with another person's goods, event or programme must still meet the content rules in regulation 5 (regulation 7).

Price promotions

A programme offering a gift or other benefit based on the value or type of service bought cannot be advertised. A payment plan may be advertised only to patients at the time payment is sought (regulation 15).

To test a draft against these rules before it runs, use the MOH ad checker; for how we build Singapore clinic campaigns around them, see healthcare marketing in Singapore.

We build Singapore aesthetic campaigns compliant-first —

• creative reviewed against the Advertisement Regulations and SMC guidance,
• run across Google Ads and Meta Ads,
• extended into Singapore social media,
• discovery on Google Business Profile through Singapore local SEO for near-me clinic searches and,
• where the audience fits, Xiaohongshu (XHS) in Singapore,
• with AI-search coverage of aesthetic and dental queries handled on our Singapore GEO / AI search optimisation service,
• SGD budgeting,
• WhatsApp automation for conversion tracking,
• and a DNC-safe follow-up.

It is exactly our Singapore aesthetic clinic programme, and the Malaysian counterpart logic is in our KKM-compliant ad copy post and the broader KKM and MDC advertising rules guide.

Clinic groups with several outlets can read how we plan and report for multi-location Singapore businesses.

1. Don't port a Malaysian campaign as-is — re-check every ad against SG's Advertisement Regulations.
2. Replace before/after and testimonials with education, credibility and process transparency.
3. Budget in SGD (CPL ~SGD 25–80; cost per consult ~SGD 120–350) and protect show-rate.
4. Build DNC/PDPA-safe consent and follow-up into the funnel before the first lead arrives.

Before publishing your next ad, run the copy through our free MOH Ad Compliance Checker — it flags testimonials, before/after language, promotional pricing and named prescription-medicine mentions in seconds. Following up with WhatsApp or SMS afterward? Check that message too with our PDPA & DNC Registry Checker.

The full rule map — SMC, SDC, HCSA, MOH circulars and the Singapore Code of Advertising Practice — is on our Singapore healthcare advertising rules page, and multi-site groups should see medical marketing in Singapore and the Singapore dental group case study.